Nrx Pharmaceuticals, Inc.
NRXP
Revenue
242.00k
▲242.00k∞%
6 Months ChangeAssets
15.00M
▲10.16M▲209.96%
3 Months ChangeLiabilities
40.75M
▲298.00k▲0.7367%
3 Months ChangeFree Cash Flow
-3.48M
▲191.00k▲5.20%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-17
Form 8-K
ID: 0001437749-26-004246
2026-02-17
Form 8-K
ID: 0001437749-26-004245
2026-02-02
Form 8-K
ID: 0001437749-26-002682
2026-01-16
Form 8-K
ID: 0001437749-26-001455
2025-12-29
Form 8-K
ID: 0001437749-25-038835
2025-11-26
Form 8-K
ID: 0001437749-25-036452
2025-11-14
Form 10-Q
ID: 0001437749-25-035210
2025-10-23
Form 8-K
ID: 0001437749-25-031637
2025-09-26
Form 8-K
ID: 0001437749-25-029907
2025-09-12
Form 8-K
ID: 0001437749-25-028949